Health & Wellness

Spurred by promising early findings, researchers are investigating whether drugs currently approved to treat heart disease can also prevent or reduce complications from Covid-19 and help hospitalized patients recover sooner.

To help protect against the coronavirus, the CDC recommends cleaning and disinfecting frequently touched surfaces daily. Bryan Warcholek, who leads the Covid-19 team for biohazard clean-up company Aftermath Services, shows how it’s done. Photo: Adam Falk/The Wall Street Journal

With stress rising and schedules upended, many are struggling to get back on track; tips from the experts on ways to get a good night’s rest.

Four people in their 70s and 80s recount how the coronavirus illness changed their lives; ‘I just wanted to go on.’

Clinicians racing to understand Covid-19 are starting to discern an unusual trend: one common symptom—the loss of smell and taste—can linger months after recovery. Doctors say it is possible some survivors may never taste or smell again.

Lilly began the first study of an experimental drug derived from a blood sample of an early U.S. survivor of Covid-19, a new effort to take advantage of the molecular defenses developed by recovered patients.

Public-health and government officials worry protests against police brutality toward African-Americans and other minority groups, spurred by the death of George Floyd in Minneapolis, could result in another jump in coronavirus cases in the coming weeks.

A 66-year-old dentist hones his hitting and fielding skills at home while waiting for the call to play ball.

A reliance on connections, rather than a systematic allocation of Covid-19 testing resources, could exacerbate the socioeconomic impact of the coronavirus pandemic.

Russia’s Ministry of Health on Saturday approved a flu drug for use in fighting coronavirus after officials said preliminary testing showed hospitalized patients who took the pills recovered more quickly.

The move comes after it found higher-than-acceptable levels of a contaminant in extended-release versions of a drug that controls high blood sugar in type-2 diabetes patients.

The Lancet said a study incorrectly reported the number of participants from Asia and Australia but overall findings of no benefit remain unchanged.

Companies that make antibody tests that are seen as key to easing lockdowns say high prices for the blood of recovered Covid-19 patients pose a hurdle to developing the tests.

Cancer patients infected with the new coronavirus are dying at significantly higher rates than Covid-19 patients in the general population, a new study suggests.

On video calls, looming heads, staring eyes, a silent audience, and that millisecond delay disrupt normal human communication.

The French health care giant is to offload most of its long-held stake in Regeneron Pharmaceuticals, giving the company a war chest to help reshape its drug pipeline as it doubles down on rare-disease and cancer medicines.

Research institutions, blood banks, companies and recovered Covid-19 patients are working to overcome a shortage of plasma donors, a major obstacle to plasma-based therapies.

As businesses and consumers come out of lockdowns, many think a key part of the solution is quick diagnostic testing that doesn’t require specialized labs. Yet experts estimate access to quality rapid tests is months away.

Novavax’s experimental coronavirus vaccine becomes one of at least 10 now being tested in people globally for Covid-19.